Kilic S

No ORCID on file · 8 papers in corpus · active 2007-2021

Study types

  • article 6
  • other 1

Condition tags

  • endometriosis 7
  • infertility 1
  • endometrioma 1
2021
Prediction of Lipoprotein-Associated Phospholipase A2 and Inflammatory Markers in Subclinical Atherosclerosis in Premature Ovarian Failure Patients.
Acta Cardiologica Sinica ·doi:10.6515/acs.202101_37(1).20200730a

BackgroundLipoprotein-associated phospholipase A2 (Lp-PLA2) activity has been associated with the risk of clinical cardiovascular events.ObjectivesIn this study, we aimed to investigate whether the activity of Lp-PLA2 presents a risk for su…

article 2014
Melatonin causes regression of endometriotic implants in rats by modulating angiogenesis, tissue levels of antioxidants and matrix metalloproteinases
Archives of gynecology and obstetrics ·doi:10.1007/s00404-014-3599-4

PurposeThe aim of this study was to test if melatonin causes regression of endometriotic implants and whether it influences implant levels of superoxide dismutase (SOD), malondialdehyde (MDA), vascular endothelial growth factor (VEGF), tiss…

article 2011
Regression of endometrial autografts in a rat model of endometriosis treated with etanercept
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2011.06.029

ObjectiveTo determine the efficacy of anti-tumor necrosis factor therapy (etanercept) for treating endometriosis in the rat endometriosis model.Study designA randomized, placebo-controlled, blinded study using rat endometriosis model. After…

article 2010
Comparison of aromatase inhibitor (letrozole) and immunomodulators (infliximab and etanercept) on the regression of endometriotic implants in a rat model
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2010.09.003

ObjectiveNovel treatment strategies are needed in the treatment of endometriosis due to limited success rates with the currently available options. As inflammatory and immunological mechanisms have been shown to be involved in the mechanism…

article 2009
Atorvastatin causes regression of endometriotic implants in a rat model
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2009.11.004

Endometriotic implants were induced surgically in female Wistar albino rats, which were randomly divided into three groups. The rats in group I (n=10) and group II (n=9) were given 2.5 mg/kg/day intraperitoneal and oral atorvastatin, respec…

article 2009
Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2009.10.873

ObjectiveWe sought to test if metformin could regress endometriotic explants in rats.Study designAfter inducing endometriotic implants and randomization of female Wistar albino rats, they were given 25 and 50 mg/kg/day of oral metformin in …

article 2008
Heterogeneous appearance of VEGF (vascular endothelial growth factor) immunopositivity in cyst capsules of endometrioma
Acta histochemica ·doi:10.1016/j.acthis.2008.04.005

The aim of the research was to reveal vascular endothelial growth factor (VEGF) immunolocalization in endometrioma cysts and endometrial tissues. The study group (group1) included 15 patients laparoscopically operated on for endometrioma an…

other 2007
Follicular fluid vascular endothelial growth factor and tumour necrosis factor alpha concentrations in patients with endometriosis undergoing ICSI
Reproductive biomedicine online ·doi:10.1016/s1472-6483(10)60345-8

The aim of this study was to investigate follicular fluid vascular endothelial growth factor (VEGF) and tumour necrosis factor alpha (TNFalpha) concentrations in endometriosis, and their effect on the outcome of intracytoplasmic sperm injec…